
																
																	Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides 
																
																
																
															Keywords: Bladder neoplasms; Transitional cell carcinoma; Chemotherapy; Antisense oligodeoxyribonucleotides; Antineoplastic combined chemotherapy protocols